_id
690daedbccc777a4e85d0abd
Ticker
ANDHF
Name
Andlauer Healthcare Group Inc
Exchange
PINK
Address
100 Vaughan Valley Boulevard, Vaughan, ON, Canada, L4H 3C5
Country
USA
Sector
Industrials
Industry
Integrated Freight & Logistics
Currency
USD
Website
https://andlauerhealthcare.com
Description
Andlauer Healthcare Group Inc. operates as a supply chain management company providing a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company provides solutions for logistics and distribution, packaging, ground transportation, air freight forwarding, and dedicated and last minute delivery. It serves healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. Andlauer Healthcare Group Inc. was formerly known as ATS Andlauer Transportation Services. The company was founded in 1991 and is based in Vaughan, Canada. As of November 1, 2025, Andlauer Healthcare Group Inc. operates as a subsidiary of United Parcel Service, Inc.
Last Close
38.11
Volume
46
Current Price
38.11
Change
0
Last Updated
2025-11-08T11:42:46.002Z
Image
-
Ipo Date
-
Market Cap
1505385600
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9755
Sentiment Sources
2
Current Quarter
2025-06-30
Revenue
156602000
Cost Of Revenue
120807000
Gross Profit
35795000
Operating Expenses
16918000
Operating Income
18877000
Interest Expense
2010000
Pretax Income
18406000
Net Income
13450000
Eps
0.33662870729570765
Dividends Per Share
4698000
Shares Outstanding
39955000
Income Tax Expense
4956000
EBITDA
38410000
Cash
58981000
Short Term Investments
-
Receivables
94064000
Inventories
5804000
Total Current Assets
165229000
Property Plant Equipment
186681000
Total Assets
687969000
Payables
34768000
Short Term Debt
87562000
Long Term Debt
-
Total Liabilities
248200000
Equity
439769000
Depreciation
17994000
Change In Working Capital
7105000
Cash From Operations
35920000
Capital Expenditures
5293000
Cash From Investing
-5027000
Cash From Financing
-15221000
Net Change In Cash
14878000
PE
30.9837
PB
3.462465635367659
ROE
3.0584238543417115
ROA
1.9550299504774198
FCF
30627000
Fcf Percent
0.1955722149142412
Piotroski FScore
4
Health Score
64
Deep Value Investing Score
5
Defensive Investing Score
7.5
Dividend Investing Score
3.5
Economic Moat Investing Score
7.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
6.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
156602000
Quarters > 0 > income Statement > cost Of Revenue
120807000
Quarters > 0 > income Statement > gross Profit
35795000
Quarters > 0 > income Statement > operating Expenses
16918000
Quarters > 0 > income Statement > operating Income
18877000
Quarters > 0 > income Statement > interest Expense
2010000
Quarters > 0 > income Statement > pretax Income
18406000
Quarters > 0 > income Statement > net Income
13450000
Quarters > 0 > income Statement > eps
0.33662870729570765
Quarters > 0 > income Statement > dividends Per Share
4698000
Quarters > 0 > income Statement > shares Outstanding
39955000
Quarters > 0 > income Statement > income Tax Expense
4956000
Quarters > 0 > income Statement > EBITDA
38410000
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
58981000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
94064000
Quarters > 0 > balance Sheet > inventories
5804000
Quarters > 0 > balance Sheet > total Current Assets
165229000
Quarters > 0 > balance Sheet > property Plant Equipment
186681000
Quarters > 0 > balance Sheet > total Assets
687969000
Quarters > 0 > balance Sheet > payables
34768000
Quarters > 0 > balance Sheet > short Term Debt
87562000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
248200000
Quarters > 0 > balance Sheet > equity
439769000
Quarters > 0 > cash Flow > net Income
13450000
Quarters > 0 > cash Flow > depreciation
17994000
Quarters > 0 > cash Flow > change In Working Capital
7105000
Quarters > 0 > cash Flow > cash From Operations
35920000
Quarters > 0 > cash Flow > capital Expenditures
5293000
Quarters > 0 > cash Flow > cash From Investing
-5027000
Quarters > 0 > cash Flow > cash From Financing
-15221000
Quarters > 0 > cash Flow > net Change In Cash
14878000
Quarters > 0 > ratios > PE
0.33662870729570765
Quarters > 0 > ratios > PB
3.462465635367659
Quarters > 0 > ratios > ROE
3.0584238543417115
Quarters > 0 > ratios > ROA
1.9550299504774198
Quarters > 0 > ratios > FCF
30627000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.1955722149142412
Quarters > 0 > health Score
64
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
166088000
Quarters > 1 > income Statement > cost Of Revenue
129339000
Quarters > 1 > income Statement > gross Profit
36749000
Quarters > 1 > income Statement > operating Expenses
15183000
Quarters > 1 > income Statement > operating Income
21566000
Quarters > 1 > income Statement > interest Expense
1956000
Quarters > 1 > income Statement > pretax Income
25448000
Quarters > 1 > income Statement > net Income
20225000
Quarters > 1 > income Statement > eps
0.5061944687773745
Quarters > 1 > income Statement > dividends Per Share
4702000
Quarters > 1 > income Statement > shares Outstanding
39955000
Quarters > 1 > income Statement > income Tax Expense
5223000
Quarters > 1 > income Statement > EBITDA
45341000
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
44103000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
113268000
Quarters > 1 > balance Sheet > inventories
5729000
Quarters > 1 > balance Sheet > total Current Assets
171108000
Quarters > 1 > balance Sheet > property Plant Equipment
191922000
Quarters > 1 > balance Sheet > total Assets
712631000
Quarters > 1 > balance Sheet > payables
47604000
Quarters > 1 > balance Sheet > short Term Debt
87659000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
268570000
Quarters > 1 > balance Sheet > equity
444061000
Quarters > 1 > cash Flow > net Income
20225000
Quarters > 1 > cash Flow > depreciation
17937000
Quarters > 1 > cash Flow > change In Working Capital
1647000
Quarters > 1 > cash Flow > cash From Operations
33037000
Quarters > 1 > cash Flow > capital Expenditures
7463000
Quarters > 1 > cash Flow > cash From Investing
-13400000
Quarters > 1 > cash Flow > cash From Financing
-16024000
Quarters > 1 > cash Flow > net Change In Cash
3620000
Quarters > 1 > ratios > PE
0.5061944687773745
Quarters > 1 > ratios > PB
3.4289997320187995
Quarters > 1 > ratios > ROE
4.554554441844702
Quarters > 1 > ratios > ROA
2.83807468381252
Quarters > 1 > ratios > FCF
25574000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.15397861374692934
Quarters > 1 > health Score
62
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
168293000
Quarters > 2 > income Statement > cost Of Revenue
128793000
Quarters > 2 > income Statement > gross Profit
39500000
Quarters > 2 > income Statement > operating Expenses
12761000
Quarters > 2 > income Statement > operating Income
26739000
Quarters > 2 > income Statement > interest Expense
2111000
Quarters > 2 > income Statement > pretax Income
24100000
Quarters > 2 > income Statement > net Income
17528000
Quarters > 2 > income Statement > eps
0.4386935302214992
Quarters > 2 > income Statement > dividends Per Share
4318000
Quarters > 2 > income Statement > shares Outstanding
39955000
Quarters > 2 > income Statement > income Tax Expense
6572000
Quarters > 2 > income Statement > EBITDA
43832000
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
40483000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
113135000
Quarters > 2 > balance Sheet > inventories
8934000
Quarters > 2 > balance Sheet > total Current Assets
168925000
Quarters > 2 > balance Sheet > property Plant Equipment
188124000
Quarters > 2 > balance Sheet > total Assets
696916000
Quarters > 2 > balance Sheet > payables
43347000
Quarters > 2 > balance Sheet > short Term Debt
61729000
Quarters > 2 > balance Sheet > long Term Debt
24895000
Quarters > 2 > balance Sheet > total Liabilities
265784000
Quarters > 2 > balance Sheet > equity
431132000
Quarters > 2 > cash Flow > net Income
17528000
Quarters > 2 > cash Flow > depreciation
17621000
Quarters > 2 > cash Flow > change In Working Capital
-12143000
Quarters > 2 > cash Flow > cash From Operations
22625000
Quarters > 2 > cash Flow > capital Expenditures
5005000
Quarters > 2 > cash Flow > cash From Investing
-4978000
Quarters > 2 > cash Flow > cash From Financing
-13990000
Quarters > 2 > cash Flow > net Change In Cash
4489000
Quarters > 2 > ratios > PE
0.4386935302214992
Quarters > 2 > ratios > PB
3.5318302747186476
Quarters > 2 > ratios > ROE
4.065576204039599
Quarters > 2 > ratios > ROA
2.5150807270890607
Quarters > 2 > ratios > FCF
17620000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.10469835346687029
Quarters > 2 > health Score
56
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
159600000
Quarters > 3 > income Statement > cost Of Revenue
122371000
Quarters > 3 > income Statement > gross Profit
37229000
Quarters > 3 > income Statement > operating Expenses
13423000
Quarters > 3 > income Statement > operating Income
23806000
Quarters > 3 > income Statement > interest Expense
2186000
Quarters > 3 > income Statement > pretax Income
22257000
Quarters > 3 > income Statement > net Income
16286000
Quarters > 3 > income Statement > eps
0.40760855962958326
Quarters > 3 > income Statement > dividends Per Share
4322000
Quarters > 3 > income Statement > shares Outstanding
39955000
Quarters > 3 > income Statement > income Tax Expense
5971000
Quarters > 3 > income Statement > EBITDA
41814000
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
35994000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
102566000
Quarters > 3 > balance Sheet > inventories
5072000
Quarters > 3 > balance Sheet > total Current Assets
153969000
Quarters > 3 > balance Sheet > property Plant Equipment
164969000
Quarters > 3 > balance Sheet > total Assets
649919000
Quarters > 3 > balance Sheet > payables
47105000
Quarters > 3 > balance Sheet > short Term Debt
59838000
Quarters > 3 > balance Sheet > long Term Debt
24837000
Quarters > 3 > balance Sheet > total Liabilities
245495000
Quarters > 3 > balance Sheet > equity
404424000
Quarters > 3 > cash Flow > net Income
16286000
Quarters > 3 > cash Flow > depreciation
17371000
Quarters > 3 > cash Flow > change In Working Capital
-2315000
Quarters > 3 > cash Flow > cash From Operations
30665000
Quarters > 3 > cash Flow > capital Expenditures
5239000
Quarters > 3 > cash Flow > cash From Investing
-4454000
Quarters > 3 > cash Flow > cash From Financing
-30787000
Quarters > 3 > cash Flow > net Change In Cash
-4738000
Quarters > 3 > ratios > PE
0.40760855962958326
Quarters > 3 > ratios > PB
3.765070940399185
Quarters > 3 > ratios > ROE
4.02696180246474
Quarters > 3 > ratios > ROA
2.505850729090856
Quarters > 3 > ratios > FCF
25426000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.1593107769423559
Quarters > 3 > health Score
62
Valuation > metrics > PE
30.9837
Valuation > metrics > PB
3.462465635367659
Valuation > final Score
38.19490364632341
Valuation > verdict
19.7% Overvalued
Profitability > metrics > ROE
3.0584238543417115
Profitability > metrics > ROA
8.140217516295566
Profitability > metrics > Net Margin
0.08588651485932491
Profitability > final Score
43
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5643872123774072
Risk > metrics > Interest Coverage
9.391542288557213
Risk > final Score
86
Risk > verdict
Low
Liquidity > metrics > Current Ratio
1.3506825799068094
Liquidity > metrics > Quick Ratio
1.3032371454263059
Liquidity > final Score
84
Liquidity > verdict
Great
Prev Valuations > 0
65.710002679812
Prev Valuations > 1
64.68169725281352
Prev Valuations > 2
62.34929059600815
Prev Profitabilities > 0
57
Prev Profitabilities > 1
54
Prev Profitabilities > 2
53
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
82
Prev Liquidities > 1
90
Prev Liquidities > 2
86
Updated At
2026-01-20T21:23:25.612Z
Andlauer Healthcare Group Inc. operates as a supply chain management company providing a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company provides solutions for logistics and distribution, packaging, ground transportation, air freight forwarding, and dedicated and last minute delivery. It serves healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. Andlauer Healthcare Group Inc. was formerly known as ATS Andlauer Transportation Services. The company was founded in 1991 and is based in Vaughan, Canada. As of November 1, 2025, Andlauer Healthcare Group Inc. operates as a subsidiary of United Parcel Service, Inc.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIndian Rupee tanks to new low near 91.50 per US dollar, NIFTY tests and half month low Business Standard
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Andlauer Healthcare Group Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.